scholarly article | Q13442814 |
P50 | author | Luis A Ortiz | Q57047577 |
P2093 | author name string | Donald G Phinney | |
Christopher L Haga | |||
Veena Krishnappa | |||
Siddaraju V Boregowda | |||
P2860 | cites work | Twist is required for thrombin-induced tumor angiogenesis and growth | Q39976250 |
The mesengenic process | Q40631427 | ||
Stretch-induced IL-8 depends on c-Jun NH2-terminal and nuclear factor-κB-inducing kinases | Q40652079 | ||
Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation | Q41120985 | ||
Differential activation of adipogenesis by multiple PPAR isoforms. | Q42814225 | ||
FGF2 stimulates the proliferation of human mesenchymal stem cells through the transient activation of JNK signaling | Q43296119 | ||
Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. | Q44058493 | ||
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation | Q44786842 | ||
Fibroblast growth factor-2 maintains a niche-dependent population of self-renewing highly potent non-adherent mesenchymal progenitors through FGFR2c | Q44998864 | ||
bFGF Administration Lowers the Phosphate Threshold for Mineralization in Bone Marrow Stromal Cells | Q46286263 | ||
MSCs: science and trials | Q46464522 | ||
Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. | Q46670167 | ||
Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity | Q47614351 | ||
The kynurenine pathway of tryptophan degradation is activated during osteoblastogenesis. | Q47820171 | ||
Onset of heterogeneity in culture-expanded bone marrow stromal cells | Q48708945 | ||
Development of mesenchymal stem cells partially originate from the neural crest | Q50605496 | ||
EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification. | Q50715828 | ||
TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment | Q50737248 | ||
Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. | Q52170394 | ||
Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice | Q53471525 | ||
Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues | Q53745526 | ||
Interferon Gamma Inhibits Adipogenesis In Vitro and Prevents Marrow Fat Infiltration in Oophorectomized Mice | Q57086312 | ||
Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF | Q74630598 | ||
Direct regulation of TWIST by HIF-1alpha promotes metastasis | Q24316939 | ||
Suppression of human ribosomal protein L23A expression during cell growth inhibition by interferon-beta | Q24324063 | ||
A perivascular origin for mesenchymal stem cells in multiple human organs | Q28131808 | ||
In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment | Q28272235 | ||
Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis | Q28304548 | ||
Regulation of chondrocyte differentiation by Cbfa1 | Q28509820 | ||
Identification of a novel response element in the rat bone sialoprotein (BSP) gene promoter that mediates constitutive and fibroblast growth factor 2-induced expression of BSP | Q28576282 | ||
Differentiation-Dependent Secretion of Proangiogenic Factors by Mesenchymal Stem Cells | Q28730445 | ||
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts | Q29547605 | ||
Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment | Q29620053 | ||
Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy | Q33490119 | ||
Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cells | Q33595161 | ||
Inflammation and Immune-Related Candidate Gene Associations with Acute Lung Injury Susceptibility and Severity: A Validation Study | Q34516108 | ||
High resolution mapping of Twist to DNA in Drosophila embryos: Efficient functional analysis and evolutionary conservation | Q34729636 | ||
g:Profiler--a web server for functional interpretation of gene lists (2011 update). | Q35075627 | ||
The MSC: An Injury Drugstore | Q35130445 | ||
Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects | Q35168236 | ||
Mesenchymal stem cell–based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α | Q35600853 | ||
A core transcriptional network for early mesoderm development in Drosophila melanogaster | Q35649396 | ||
Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury | Q35841729 | ||
Twist-1 induces Ezh2 recruitment regulating histone methylation along the Ink4A/Arf locus in mesenchymal stem cells. | Q35867912 | ||
WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4. | Q36616934 | ||
Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts | Q36681378 | ||
Chronic inflammation: a failure of resolution? | Q36780168 | ||
Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy | Q37000326 | ||
Mesenchymal stem cell preparations--comparing apples and oranges | Q37029988 | ||
A Myc-Slug (Snail2)/Twist regulatory circuit directs vascular development | Q37341313 | ||
Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease | Q37970678 | ||
Mesenchymal stromal cells: sensors and switchers of inflammation | Q38149359 | ||
Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation. | Q38186634 | ||
Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations | Q39450188 | ||
P921 | main subject | clinical indication | Q110971784 |
P304 | page(s) | 62-73 | |
P577 | publication date | 2015-12-24 | |
P1433 | published in | EBioMedicine | Q24912341 |
P1476 | title | A Clinical Indications Prediction Scale Based on TWIST1 for Human Mesenchymal Stem Cells | |
P478 | volume | 4 |
Q37655668 | Advancing mesenchymal stem/stromal cells-based therapies for neurologic disease. |
Q38710511 | Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs |
Q90090969 | Depletion of ID3 enhances mesenchymal stem cells therapy by targeting BMP4 in Sjögren's syndrome |
Q92495885 | EP4 Antagonist-Elicited Extracellular Vesicles from Mesenchymal Stem Cells Rescue Cognition/Learning Deficiencies by Restoring Brain Cellular Functions |
Q50058049 | Effect of Multiple Intraperitoneal Injections of Human Bone Marrow Mesenchymal Stem Cells on Cuprizone Model of Multiple Sclerosis |
Q52682434 | Evidences for a New Role of miR-214 in Chondrogenesis. |
Q55319551 | Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study. |
Q37591617 | Long noncoding RNA Braveheart promotes cardiogenic differentiation of mesenchymal stem cells in vitro |
Q101051167 | Magnetic separation of peripheral nerve-resident cells underscores key molecular features of human Schwann cells and fibroblasts: an immunochemical and transcriptomics approach |
Q91726412 | Mesenchymal Stem Cell Therapy for Spinal Cord Contusion: A Comparative Study on Small and Large Animal Models |
Q47901024 | Mesenchymal Stem Cells: The Moniker Fits the Science. |
Q41212597 | Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Can Preconditioning Strategies Improve Therapeutic Efficacy? |
Q97519174 | Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers |
Q91792198 | Mesenchymal stem cell perspective: cell biology to clinical progress |
Q42348036 | Mesenchymal stromal cells and ischemic heart disease: hitting the target? |
Q42051201 | Quantifiable Metrics for Predicting MSC Therapeutic Efficacy |
Q90149952 | Recent advances in understanding mesenchymal stromal cells |
Q41192304 | Shift of EMT gradient in 3D spheroid MSCs for activation of mesenchymal niche function |
Q90408315 | Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases 2017. An Official American Thoracic Society Workshop Report |
Q64925846 | The Therapeutic Potential of Stem Cells for Bronchopulmonary Dysplasia: "It's About Time" or "Not so Fast" ? |
Search more.